Company: PIII
Filing Date: 2025-04-04
Form Type: 8-K
Source: 0001628280-25-016833
Chunk: 0

Company: P3 Health Partners Inc.
Filing Date: 2025-04-04
Form: 8-K
Item: Item 8.01
Chunk 0
---
Item 8.01 Other Events.

As previously disclosed, on March 31, 2025, P3 Health Partners Inc., a Delaware corporation (the “ Company”) held a Special Meeting of Stockholders at which the stockholders of the Company approved amendments to the Company’s Amended and Restated Certificate of Incorporation to effect a reverse stock split of all outstanding shares of the Company’s Class A common stock, $0.0001 par value per share, and Class V common stock, $0.0001 par value per share (collectively, the “common stock”), at a ratio ranging from any whole number between 1-for-10 and 1-for-60, with the exact ratio as determined by the Board of Directors of the Company (the “ Board”) in its discretion, subject to the Board’s authority to abandon such amendments. On April 1, 2025 the Board approved a reverse stock split of the Company’s common stock at a final ratio of 1-for-50 (the “ Reverse Stock Split”) and abandoned all other amendments. The Reverse Stock Split is expected to become effective at 5:00 p. m. Eastern Time on April 11, 2025 (the “ Effective Date”), following the filing of a Certificate of Amendment to the Amended and Restated Certificate of Incorporation with the Secretary of State of the State of Delaware, in substantially the form set forth in Appendix A to the Company’s Definitive Proxy Statement on Schedule 14A filed with the Securities and Exchange Commission (the “ SEC”) on March 3, 2025. The Company’s Class A common stock is expected to commence trading on a split-adjusted basis when the markets open on April 14, 2025, under the existing trading symbol “ PIII.” The new CUSIP number for the Class A common stock following the Reverse Stock Split will be 744413 204. The par value and other terms of the common stock will not be affected by the Reverse Stock Split. The Company’s public warrants will continue to trade on Nasdaq under the ticker symbol “ PIIIW” with the same CUSIP number.

Proportional adjustments will be made to the number of shares of Class A common stock underlying the Company’s outstanding equity awards, and warrants, and to the number of shares issuable under the Company’s equity incentive plans and other existing agreements, as well as the exercise or conversion price, as applicable.

No fractional shares will be issued as a result of the Reverse Stock